financetom
Business
financetom
/
Business
/
Celsius Holdings Stock Bounces Back From Steep Sell-Off
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Celsius Holdings Stock Bounces Back From Steep Sell-Off
Nov 10, 2025 6:37 AM

Celsius Holdings Inc ( CELH ) shares are moving higher Monday after the company announced a $300 million share repurchase authorization.

CELH stock is racing ahead of the pack. See what the experts say here.

What Happened: Celsius said its board approved a new buyback program to repurchase up to $300 million of its common stock. Repurchases may be made from time to time in open market transactions, privately negotiated transactions or through trading plans.

“This authorization gives us the flexibility to act when we see a disconnect between Celsius’ market valuation and the underlying strength of our business fundamentals,” said John Fieldly, chairman and CEO of Celsius Holdings ( CELH ).

“We have a strong balance sheet and robust cash generation, which allow us to opportunistically repurchase shares when we believe they are undervalued – such as at times like these – while maintaining ample capacity to invest in our growth and reduce debt.”

The repurchase authorization comes after Celsius shares sold off last week after the company reported third-quarter financial results that included $246.7 million in distributor termination costs.

Following the company’s quarterly results, JPMorgan, Citigroup, UBS, BofA and Stifel all lowered price targets on the stock, ranging from $50 to $68.

Celsius will participate in upcoming investor conferences including the JPMorgan U.S. Opportunities Forum on Nov. 12, the Stephens Annual Investment conference on Nov. 19 and the Morgan Stanley Global Consumer and Retail conference on Dec. 3.

How To Buy CELH Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Celsius Holdings' ( CELH ) case, it is in the Consumer Staples sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

CELH Price Action: Celsius shares were up 5.49% at $43.80 at the time of publication on Monday, according to Benzinga Pro. Celsius stock was trading above $60 last week before reporting third-quarter results.

Read Next:

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Secretly Monitor But Don’t Talk About Yet

Image: MDV Edwards/Shutterstock.com

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools
Sophia Genetics Forms Partnership With Strand Life Sciences to Advance Diagnostic Tools
Apr 4, 2024
03:36 AM EDT, 04/04/2024 (MT Newswires) -- Sophia Genetics ( SOPH ) said Thursday it had formed a partnership with Strand Life Sciences to advance genomic technologies and diagnostic tools. The two medical informatics firms did not disclose the financial terms behind their collaboration. Swiss-based Sophia will combine its cloud-based genomics tools with India-based Strand's databases to expand their ability...
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb
Standard BioTools Enters Into Multi-Year Medicine Research Engagement With Bristol-Myers Squibb
Apr 4, 2024
03:35 AM EDT, 04/04/2024 (MT Newswires) -- Standard BioTools ( LAB ) said late Wednesday it agreed to enter into a multi-year strategic engagement with Bristol-Myers Squibb ( BMY ) for the use of the SomaScan platform for translational medical research through 2026. The financial terms of the agreement weren't disclosed. The SomaScan platform is a proteomics technology that provides...
Volaris Says Passenger Demand, Capacity Declined in March
Volaris Says Passenger Demand, Capacity Declined in March
Apr 4, 2024
03:33 AM EDT, 04/04/2024 (MT Newswires) -- Controladora Vuela Compania de Aviacion, S.A.B. de C.V. (Volaris) (VLRS) reported late Wednesday a 15% drop in passenger demand in March on a capacity decrease of 16%. For the month of March, passenger demand, measured as revenue passenger miles, fell to 2.4 million; capacity, measured as available seat miles, decreased to 2.7 million;...
AbbVie Flags Hit to Q1 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook
AbbVie Flags Hit to Q1 Adjusted Earnings from R&D Expenses, Revises 2024 Outlook
Apr 4, 2024
03:31 AM EDT, 04/04/2024 (MT Newswires) -- AbbVie ( ABBV ) said late Wednesday it expects its Q1 2024 per-share adjusted earnings to take a $0.08 hit from acquired in-process research and development and milestones expense of $164 million on a pre-tax basis. The company expects Q1 adjusted EPS of $2.18 to $2.22, including the impact, according to a regulatory...
Copyright 2023-2026 - www.financetom.com All Rights Reserved